{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:28:25Z","timestamp":1791332905760,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,6,10]],"date-time":"2004-06-10T00:00:00Z","timestamp":1086825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,6,10]],"date-time":"2004-06-10T00:00:00Z","timestamp":1086825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.1038\/sj.leu.2403400","type":"journal-article","created":{"date-parts":[[2004,6,10]],"date-time":"2004-06-10T09:28:17Z","timestamp":1086859697000},"page":"1357-1363","source":"Crossref","is-referenced-by-count":106,"title":["Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro"],"prefix":"10.1038","volume":"18","author":[{"given":"Y","family":"Satou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-i","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Toyokuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,6,10]]},"reference":[{"key":"BF2403400_CR1","first-page":"73","volume-title":"Topic in Hematology, the 16th International Congress of Hematology","author":"K Takatsuki","year":"1977","unstructured":"Takatsuki K, Uchiyama T, Sagawa K, Yodoi J . Adult T cell leukemia in Japan. In: Seno S, Takaku F, Irino S (eds). Topic in Hematology, the 16th International Congress of Hematology. Amsterdam: Excerpta Medica, 1977, pp 73\u201377."},{"key":"BF2403400_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H . Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481\u2013492.","journal-title":"Blood"},{"key":"BF2403400_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375\u2013382.","journal-title":"Br J Haematol"},{"key":"BF2403400_CR4","first-page":"221","volume-title":"Adult T-cell leukemia\/lymphoma","author":"M Matsuoka","year":"2000","unstructured":"Matsuoka M . Adult T-cell leukemia\/lymphoma, In: Goedert JJ (ed). Infectious Causes of Cancer. Totowa: Humana Press, 2000, pp 221\u2013229."},{"key":"BF2403400_CR5","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood.V97.10.3177","volume":"97","author":"J Yasunaga","year":"2001","unstructured":"Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001; 97: 3177\u20133183.","journal-title":"Blood"},{"key":"BF2403400_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida M . Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475\u2013496.","journal-title":"Annu Rev Immunol"},{"key":"BF2403400_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1359-6101(00)00028-9","volume":"12","author":"KT Jeang","year":"2001","unstructured":"Jeang KT . Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev 2001; 12: 207\u2013217.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF2403400_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.2497518","volume":"244","author":"B Hoyos","year":"1989","unstructured":"Hoyos B, Ballard DW, Bohnlein E, Siekevitz M, Greene WC . Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 1989; 244: 457\u2013460.","journal-title":"Science"},{"key":"BF2403400_CR9","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW et al. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 1999; 93: 2360\u20132368.","journal-title":"Blood"},{"key":"BF2403400_CR10","first-page":"2615","volume":"59","author":"J Adams","year":"1999","unstructured":"Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999; 59: 2615\u20132622.","journal-title":"Cancer Res"},{"key":"BF2403400_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.leu.2402417","volume":"16","author":"JB Almond","year":"2002","unstructured":"Almond JB, Cohen GM . The proteasome: a novel target for cancer chemotherapy. Leukemia 2002; 16: 433\u2013443.","journal-title":"Leukemia"},{"key":"BF2403400_CR12","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa030288","volume":"348","author":"PG Richardson","year":"2003","unstructured":"Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003; 348: 2609\u20132617.","journal-title":"N Engl J Med"},{"key":"BF2403400_CR13","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","volume":"101","author":"T Hideshima","year":"2003","unstructured":"Hideshima T, Mitsiades C, Akiyama M, Hayashi T, Chauhan D, Richardson P et al. Molecular mechanisms mediating anti-myeloma activity of proteasome inhibitor PS-341. Blood 2003; 101: 1530\u20131534.","journal-title":"Blood"},{"key":"BF2403400_CR14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.V70.5.1407.1407","volume":"70","author":"M Maeda","year":"1987","unstructured":"Maeda M, Arima N, Daitoku Y, Kashihara M, Okamoto H, Uchiyama T et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 1987; 70: 1407\u20131411.","journal-title":"Blood"},{"key":"BF2403400_CR15","first-page":"1043","volume":"60","author":"K Nosaka","year":"2000","unstructured":"Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M . Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res 2000; 60: 1043\u20131048.","journal-title":"Cancer Res"},{"key":"BF2403400_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","volume":"109","author":"S Takeda","year":"2004","unstructured":"Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004; 109: 559\u2013567.","journal-title":"Int J Cancer"},{"key":"BF2403400_CR17","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1182\/blood-2003-05-1605","volume":"103","author":"M Okada","year":"2004","unstructured":"Okada M, Adachi S, Imai T, Watanabe KI, Toyokuni SY, Ueno M et al. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 2004; 103: 2299\u20132307.","journal-title":"Blood"},{"key":"BF2403400_CR18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/aid.1994.10.1259","volume":"10","author":"KF Copeland","year":"1994","unstructured":"Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, Heeney JL . Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses 1994; 10: 1259\u20131268.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"BF2403400_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0092-8674(00)81466-X","volume":"93","author":"S Yamaoka","year":"1998","unstructured":"Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93: 1231\u20131240.","journal-title":"Cell"},{"key":"BF2403400_CR20","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1074\/jbc.274.25.17402","volume":"274","author":"DY Jin","year":"1999","unstructured":"Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT . Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J Biol Chem 1999; 274: 17402\u201317405.","journal-title":"J Biol Chem"},{"key":"BF2403400_CR21","first-page":"1083","volume":"62","author":"C Tan","year":"2002","unstructured":"Tan C, Waldmann TA . Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res 2002; 62: 1083\u20131086.","journal-title":"Cancer Res"},{"key":"BF2403400_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ni0503-416","volume":"4","author":"M Jaattela","year":"2003","unstructured":"Jaattela M, Tschopp J . Caspase-independent cell death in T lymphocytes. Nat Immunol 2003; 4: 416\u2013423.","journal-title":"Nat Immunol"},{"key":"BF2403400_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489\u2013495.","journal-title":"Nat Immunol"},{"key":"BF2403400_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1083\/jcb.151.6.1247","volume":"151","author":"H Matsumura","year":"2000","unstructured":"Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S . Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000; 151: 1247\u20131256.","journal-title":"J Cell Biol"},{"key":"BF2403400_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1006\/bbrc.2001.5678","volume":"287","author":"RG Uzzo","year":"2001","unstructured":"Uzzo RG, Dulin N, Bloom T, Bukowski R, Finke JH, Kolenko V . Inhibition of NFkappaB induces caspase-independent cell death in human T lymphocytes. Biochem Biophys Res Commun 2001; 287: 895\u2013899.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2403400_CR26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood.V91.7.2467","volume":"91","author":"A Lau","year":"1998","unstructured":"Lau A, Nightingale S, Taylor GP, Gant TW, Cann AJ . Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy. Blood 1998; 91: 2467\u20132474.","journal-title":"Blood"},{"key":"BF2403400_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1073\/pnas.92.2.552","volume":"92","author":"YC Lin","year":"1995","unstructured":"Lin YC, Brown K, Siebenlist U . Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc Natl Acad Sci USA 1995; 92: 552\u2013556.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403400","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:46:27Z","timestamp":1648777587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,10]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8,1]]}},"alternative-id":["BF2403400"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403400","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,10]]}}}